ReviewReviews in medical virology2026
Oncoviruses at the Crossroads of Ageing and Cancer: Molecular Mechanisms and Key Signalling Pathways.
Review in Reviews in medical virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Oncoviruses are responsible for a substantial fraction of human cancers and have emerged as critical modulators of host cellular pathways that also govern ageing. The convergence of viral oncogenesis, ageing, and cancer reflects shared molecular mechanisms, including genomic instability, epigenetic alterations, telomere attrition, and chronic inflammation. Increasing evidence indicates that oncoviruses such as human papillomavirus, Epstein-Barr virus, hepatitis B and C viruses, and Kaposi's sarcoma-associated herpesvirus actively reprogramme host signalling networks to promote persistent infection, immune evasion, and malignant transformation. This review synthesises current knowledge on how oncoviruses intersect with key hallmarks of ageing and cancer, with particular emphasis on the signalling pathways that bridge these processes. Central pathways, including p53, mTOR, NF-κB, PI3K/AKT, and Wnt/β-catenin, are frequently targeted by viral proteins, leading to dysregulated cell survival, proliferation, and senescence. These interactions not only facilitate tumourigenesis but also accelerate ageing-associated cellular dysfunctions, such as immunosenescence and inflammaging. Furthermore, we discuss how virus-induced modulation of the tumour microenvironment and host immune responses contributes to the dynamic interplay between ageing and cancer. Understanding these interconnected pathways provides valuable insights into the dual role of oncoviruses as drivers of both age-related decline and cancer development. Elucidating these mechanisms may reveal novel therapeutic targets and strategies for preventing and treating virus-associated malignancies in ageing populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.